Table 1: WHO recommendations for the diagnostic criteria for diabetes and intermediate hyperglycaemia in the non pregnant population. Diabetes Fasting plasma glucose ≥7.0mmol/l or 2–h plasma glucose* ≥11.1mmol/l Impaired Glucose Tolerance (IGT) Fasting plasma glucose <7.0mmol/l and 2–h plasma glucose* ≥7.8 and <11.1mmol/l Impaired Fasting Glucose (IFG) Fasting plasma glucose 6.1 to 6.9mmol/l and (if [...]
Analyses Find Type 2 Diabetes Patients Treated with Bydureon Experienced Reduction in Cardiovascular Risk Factors Eli Lilly & company (Ireland) ltd. wish to announce that Bydureon (exenatide extended-release for injectable suspension) is now available in Ireland as a one weekly injection for the treatment of type 2 diabetes mellitus in combination with metformin, sulphonylurea, and/or [...]
Prevalence At least 141,000 adults in Ireland (4.7%) have diabetes (diagnosed or undiagnosed) The number of people affected by diabetes in Ireland is increasing. This number is expected to rise to 194,000 or 5.6 % of the population by 2015 – a 37% increase1. In excess of 10% of healthcare spending in Ireland is diabetes [...]
Company: Boehringer Ingelheim Ireland Ltd and Eli Lilly & Company (Ireland) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Linagliptin 5mg. Description: Round, light red film-coated tablet marked D5 on one side and the Boehringer Ingelheim logo on the other. Presentation: 28, €38.01. Indications: Treatment of type 2 diabetes mellitus to improve glycaemic control [...]
Dear Editor, I read, with interest, the recent article written by Gary Culliton on diabetes care (‘National retinopathy roll-out set for 2012’, September 9, 2011, http://bit.ly/onJIdF). It is tremendous to be finally discussing the prospect of a national screening programme for diabetic retinopathy to run in tandem with screening services for other complications of diabetes, [...]
Retinopathy screening for patients with diabetes is scheduled for 2012 and is just one aspect of the HSE’s National Clinical Programme for Diabetes, writes Gary Culliton.
By Gary Culliton. The HSE has launched a new Contraception and Pregnancy with Diabetes information leaflet for women with type I or type II diabetes. The publication was developed to target women with diabetes in order to promote the concept of either actively planning to conceive or actively avoiding pregnancy.
By Gary Culliton A cross-border diabetes project is under way to tackle two high-risk clinical areas associated with the condition — improving pregnancy outcomes for women with diabetes
Dr Deirdre Carroll looks at the relationship between obesity and the development of type II diabetes and examines recent guidance on the management of obesity.
Patients who take high-dose statins face an increased risk of developing diabetes compared with lower doses, research finds.
Loading ...
